Literature DB >> 28129497

Metabolic Syndrome and Symptom Resolution in Depression: A 5-Year Follow-Up of Older Adults.

Marianna Virtanen1,2, Jane E Ferrie3,4, Tasnime Akbaraly3,5,6,7, Adam Tabak3,8, Markus Jokela9, Klaus P Ebmeier10, Archana Singh-Manoux3,11, Mika Kivimäki3,12.   

Abstract

OBJECTIVE: Although metabolic syndrome is associated with the incidence of depression, little is known about its contribution to the course of depression. We examined whether metabolic syndrome and its components are associated with long-term symptom resolution in older adults with depressive symptoms.
METHODS: Data from 965 participants in the Whitehall II cohort study (mean age = 62 years at baseline) were used to generate 1,172 person-observations of metabolic syndrome and its components (abdominal obesity, low level of high-density lipoprotein [HDL] cholesterol, high level of triglycerides, hypertension, and elevated fasting glucose or diabetes). All participants were depression cases at the beginning of 2 consecutive follow-up cycles: from 2002-2004 to 2007-2009 and from 2007-2009 to 2012-2013 (mean follow-up = 4.6 years). Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression scale caseness at the beginning and the end of the 2 cycles.
RESULTS: In multivariable adjusted analyses, metabolic syndrome per se was not associated with symptom resolution. Of its components, low HDL cholesterol (risk ratio [RR] = 0.82; 95% CI, 0.68-1.00; P = .045) and high triglyceride levels (RR = 0.81; 95% CI, 0.70-0.95; P = .007) were associated with a lower likelihood of symptom resolution. These findings were replicated in a subpopulation without coronary heart disease and stroke (RR = 0.77 [95% CI, 0.63-0.95; P = .015] for low HDL cholesterol; RR = 0.79 [95% CI, 0.67-0.94; P = .006] for high triglycerides).
CONCLUSIONS: Low HDL cholesterol and high triglyceride levels are associated with lower likelihood of long-term symptom resolution in depression. These data suggest that an adverse lipid profile, but not other components of metabolic syndrome, may delay recovery from depression. © Copyright 2017 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28129497     DOI: 10.4088/JCP.15m10399

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  Long-term exposure to greenspace and metabolic syndrome: A Whitehall II study.

Authors:  Carmen de Keijzer; Xavier Basagaña; Cathryn Tonne; Antònia Valentín; Jordi Alonso; Josep M Antó; Mark J Nieuwenhuijsen; Mika Kivimäki; Archana Singh-Manoux; Jordi Sunyer; Payam Dadvand
Journal:  Environ Pollut       Date:  2019-09-13       Impact factor: 8.071

2.  Association between the change of total cholesterol during adolescence and depressive symptoms in early adulthood.

Authors:  Ji Hye Park; Sun Jae Jung; YunJae Jung; Song Vogue Ahn; Eun Lee; Hyeon Chang Kim
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-03-19       Impact factor: 4.785

3.  Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression.

Authors:  Wenxia Jiang; Lei Gong; Fang Liu; Yikun Ren; Jun Mu
Journal:  Front Cell Infect Microbiol       Date:  2021-04-22       Impact factor: 5.293

4.  High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.

Authors:  Ricard Navinés; Giovanni Oriolo; Igor Horrillo; Myriam Cavero; Bruno Aouizerate; Martin Schaefer; Lucile Capuron; J Javier Meana; Rocio Martin-Santos
Journal:  Int J Neuropsychopharmacol       Date:  2022-06-21       Impact factor: 5.678

5.  Prospective plasma lipid profiling in individuals with and without depression.

Authors:  Dietmar Enko; Wolfgang Brandmayr; Gabriele Halwachs-Baumann; Wolfgang J Schnedl; Andreas Meinitzer; Gernot Kriegshäuser
Journal:  Lipids Health Dis       Date:  2018-06-26       Impact factor: 3.876

Review 6.  The Bidirectional Relationship between Diabetes and Depression: A Literature Review.

Authors:  Abdallah Alzoubi; Rnad Abunaser; Adi Khassawneh; Mahmoud Alfaqih; Aws Khasawneh; Nour Abdo
Journal:  Korean J Fam Med       Date:  2018-05-18

7.  Predictors of polypharmacy among elderly Thais with depressive and anxiety disorders: findings from the DAS study.

Authors:  Nahathai Wongpakaran; Tinakon Wongpakaran; Thanitha Sirirak; Rewadee Jenraumjit; Surin Jiraniramai; Peerasak Lerttrakarnnon
Journal:  BMC Geriatr       Date:  2018-12-12       Impact factor: 3.921

Review 8.  Oxidative Stress-Related Endothelial Damage in Vascular Depression and Vascular Cognitive Impairment: Beneficial Effects of Aerobic Physical Exercise.

Authors:  Maria Luca; Antonina Luca
Journal:  Oxid Med Cell Longev       Date:  2019-12-20       Impact factor: 6.543

9.  The relationship between depression and risk of metabolic syndrome: a meta-analysis of observational studies.

Authors:  Yousef Moradi; Ahmed N Albatineh; Hassan Mahmoodi; Reza Ghanei Gheshlagh
Journal:  Clin Diabetes Endocrinol       Date:  2021-03-02

Review 10.  Pathomechanisms of Vascular Depression in Older Adults.

Authors:  Kurt A Jellinger
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.